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protective ffect on joint carti lage proteoglycan (PG) content (p < 0.0005) and biosynthesis as measured by 
3~S-PG specific activity (p < 0.0005) relative to carti lage of non-drug treated PC controls [1]. In the present 
investigation, the effects of CaPPS on the ex vivo metabolism of knee joint synovial fibroblasts (RSF) from 
the same model were also evaluated. 
Methods  
Ten rabbits were used for this study. Two remained untreated while the others had one knee joint injected 
with the PC complex 24 h before sacrifice. Commencing 8 days before sacrifice, four of the PC-treated rabbits 
were orally dosed every second day with 10 mg/kg CaPPS. At sacrifice, the synovium was dissected from each 
knee joint under sterile conditions and the RSF isolated and cultured. Cell lines (n = 20) were grown to the 
3rd passage and then frozen in liquid N2. Cells of 15 lines were plated at equal densities and incubated for 
24 h ± interleukin-l(IL-1). Ex  vivo production of nitric oxide (NO) in culture was determined as nmoles 
nitrite/pg DNA in RSF media using the Griess reagent [2]. IL-6 in media was assayed by proliferation of 7TD1 
cells [3] and RSF DNA content determined by proteinase K digestion and fluorescence after binding to 
Hoechst 33258 dye [4]. 
Resu l ts  
In RSF derived from non-PC injected joints, addition of 40 pg/ml IL-1 in vitro caused a significant decrease 
in cellular DNA content (0.24 + 0.02 to 0.18 ___ 0.01 pg DNA/well, p < 0.05), an increase in NO production 
(3.03 ± 0.25 to 5.71 ± 0.45 nmol/#g DNA, p < 0.02) and an increase in IL-6 activity (17.0 ,,, 2.0 to 
124 __+ 18 pg/#g DNA, p < 0.05). In contrast, in RSF derived from inflamed synovium of PC-injected joints, 
DNA content was already significantly reduced compared to the non-PC controls (0.16 _± 0.01 pg DNA/well, 
p < 0.02). Furthermore, NO production (4.17 ___ 0.16 nmol/pg DNA) and IL-6 activity (105 ± 17 pg//~g DNA) 
were significantly increased in these PC-RSF compared to  non-PC controls (p < 0.05). The addition of 
40 pg/ml IL-1 to these cell cultures did not cause additional changes in the measured parameters. 
RSF isolated from PC joints of rabbits treated with CaPPS exhibited DNA contents, NO production and IL-6 
activities imilar to RSF from non-PC joints of control animals. Moreover, the addition of 40 pg/ml IL-1 to 
RSF cultures from PCjo ints  of CaPPS treated animals maintained DNA content (0.25 ± 0.02 pg/well) above 
non-PC RSF levels. Although NO production was not significantly altered, IL-6 activity (85 ± 9 pg/pg DNA) 
stimulated by the presence of IL-1 was significantly lower in RSF from PC joints of CaPPS-treated animals 
compared to IL-6 activity (151 __+ 12 pg/#g DNA) in cells from PC joints of non-drug treated rabbits (p < 0.02). 
Conc lus ion  
These data show that in vitro RSF derived from inflamed (PC) joints respond differently to exposure to IL-1 
than RSF from non-inflamed control joints. However, pretreatment of animals with oral CaPPS provided 
protection to RSF by modulating the deleterious effects of IL-1 on synovial cell functions, including 
proliferation and production of NO and IL-6. On the basis of these findings we conclude that CaPPS protects 
carti lage PGs both directly and via modulation of synovial cell release of NO and cytokines. 
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Both cartilage and subchondral bone are implicated in the pathogeny of osteoarthrosis (OA). Aggrecan 
synthesis rates and the capability of secreting large aggrecan aggregates are diminished in cartilage of 
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ageing human subjects. The inability to accumulate the right type of extracellular matrix components may 
be regarded as a failure of intrinsic repair by articular cartilage cells. Increased coagulant activity in 
subchondral bone of OA patients can explain the venous congestion occurring in OA subchondral bone. This 
venous congestion causes pain and malnutrition of the subchondral tissue. 
Some oversulphated polysaccharides are known to stimulate the synthesis and to inhibit catabolism of 
extracellular matrix components and therefore, are believed to protect articular cartilage in OA. Amongst 
these polysaccharides, calcium pentosan polysulphate (CaPPS) was shown to increase IL-6 production and 
proteoglycan (aggrecan) synthesis of chondrocytes cultured in agarose. Aggrecan aggregate molecular sizes 
was significantly increased in the presence of CaPPS. This effect was largely due to an increase in the length 
of the hyaluronan backbone, to which larger numbers of aggrecan monomer units could be attached. In vivo, 
intra-articular dministration ofCaPPS was also shown to increase hyaluronan chain length in synovial fluid 
of patients with inflammatory joint diseases. These oversulphated polysaccharides also have anti-coagulant 
effects and are known to enhance fibrinolytic activity in blood. Therefore, they may improve microcirculation 
in subchondral bone. 
The pleiotropic effects on connective tissue cells o~ these oversulphated polysaccharides m~y be explained 
by an interference with a key-factor in the regulation of connective tissue metabolism. Therefore, studies 
were undertaken i order to identify serological parameters which could correlate with the pathology of OA 
and/or with clinical improvement following therapy. 
Twenty-three patients uffering from OA of the hips, knees or fingerjoints were given five injections of C aPPS 
(2 mg/kg; once weekly) subcutaneously. Their clinical symptoms were recorded at start and during a 16-week 
period. Plasma coagulant and fibrinolytic activity were assayed at the start and after 1, 2,~4, 8, 24 hours of 
the first injection. These parameters were complemented with liver, kidney function and lipid assays and 
peripheral blood cell counts during each clinical visit. These studies howed that pain scores and functional 
indices improved significantly after 3-4 injections in patients with OA of knee and fingerjoints. Coagulant 
activities were significantly decreased 2-4 hours after administration. Statistically significant increases in 
serum fibrinolytic activity were recorded 24 hours after one CaPPS injection [tPA (tissue pl'asminogen 
activator activity) increased after 8 and 24 hours and (PAI) plasminogen activator inhibitor activity 
decreased after 4 and 8 hours and continued to decrease 12 weeks after the fifth injection]. Raised plasma 
alpha-anti-trypsin inhibitor activities may have correlated with decreased elastase activities and hence with 
decreased potential for destruction of connective tissues. An increase in acute-phase r sponse in PPS-treated 
patients may be the consequence ofa stimulation of IL-6-release (in vitro finding) by their connective tissue 
cells. 
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In t roduct ion  
At present patients with OA and their response to drug treatments are usually followed longitudinally using 
clinical and/or radiological methods of assessment. While several validated methods of measuring clinical 
outcomes in OA patients have been described [1], none provides a sensitive index of the pathological status 
of the disease. Molecular markers of cartilage and bone turnover have been quantitated in patient's ynovial 
fluid (SF) or sera and have shown correlations with radiological grading of hard tissue pathology [2] [3]. 
However, to date these markers have not been correlated with clinical symptoms or used to monitor the 
response of OA patients to disease modifying drug therapies. We have previously proposed that the 
